Modelling lymphocytic leukaemia incidence in England and Wales using generalizations of the two-mutation model of carcinogenesis of Moolgavkar, Venzon and Knudson

Statistics in Medicine

Volumn 15, Issue 10, 1996, Pages 1003-1022

  Little, M P ^a   Muirhead, C R ^a   Stiller, C A ^b  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b Childhood Cancer Research Group   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; CARCINOGENESIS; CELL POPULATION; CHRONIC LYMPHATIC LEUKEMIA; INCIDENCE; LYMPHATIC LEUKEMIA; MODEL; MUTATION RATE; POPULATION RESEARCH; STEM CELL; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; CARCINOGENS; CHILD; CHILD, PRESCHOOL; DISEASE SUSCEPTIBILITY; ENGLAND; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MIDDLE AGED; MODELS, GENETIC; MUTATION; SEX FACTORS; WALES;

EID: 0029937543     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0258(19960530)15:10<1003::AID-SIM214>3.0.CO;2-3     Document Type: Article

References (47)

1. Doll, R. 'The age distribution of cancer: implications for models of carcinogenesis', Journal of the Royal Statistical Society, Series A, 132, 133-166 (1971).
2. Armitage, P. and Doll, R. 'The age distribution of cancer and a multi-stage theory of carcinogenesis', British Journal of Cancer, 8, 1-12 (1954).
3. BEIR V. National Research Council Advisory Committee on the Biological Effects of Ionizing Radiations. 'Health effects of exposure to low levels of ionizing radiation', National Academy of Sciences, Washington DC, 1990.
4. Little, M. P. 'Risks of radiation-induced cancer at high doses and dose rates', Journal of Radiological Protection, 13, 3-25 (1993).
5. Little, M. P., Hawkins, M. M., Charles, M. W. and Hildreth, N. G. 'Fitting the Armitage-Doll model to radiation-exposed cohorts and implications for population cancer risks', Radiation Research, 132, 207-221 (1992).
6. Little, M. P., Hawkins, M. M., Charles, M. W. and Hildreth, N. G. 'Corrections to the paper "Fitting the Armitage-Doll model to radiation-exposed cohorts and implications for population cancer risks" (letter)', Radiation Research, 137, 124-128 (1994).
7. Armitage, P. and Doll, R. 'A two-stage theory of carcinogenesis in relation to the age distribution of human cancer', British Journal of Cancer, 9, 161-169 (1957).
8. Knudson, A. G. 'Mutation and cancer: statistical study of retinoblastoma', Proceedings of the National Academy of Sciences U.S.A., 68, 820-823 (1971).
9. Moolgavkar, S. H. and Venzon, D. J. 'Two-event models for carcinogenesis: incidence curves for childhood and adult tumors', Mathematical Biosciences, 47, 55-77 (1979).
10. Tucker, H. G. 'A stochastic model for a two-stage theory of carcinogenesis', in Fifth Berkeley Symposium on Mathematical Statistics and Probability, University of California Press, Berkeley, 1967, pp. 387-403.
11. Moolgavkar, S. H. and Knudson, A. G. 'Mutation and cancer: a model for human carcinogenesis', Journal of the National Cancer Institute, 66, 1037-1052 (1981).
12. Tan, W.-Y. Stochastic Models of Carcinogenesis, Marcel Dekker, New York, 1991.
13. Moolgavkar, S. H., Dewanji, A. and Venzon, D. J. 'A stochastic two-stage model for cancer risk assessment. I. The hazard function and the probability of tumor', Risk Analysis, 8, 383-392 (1988).
14. Little, M. P. and Charles, M. W. 'Time variations in radiation-induced relative risk and implications for population cancer risks', Journal of Radiological Protection, 11, 91-110 (1991).
15. Moolgavkar, S. H., Cross, F. T., Luebeck, G. and Dagle, G. E. 'A two-mutation model for radon-induced lung tumors in rats', Radiation Research, 121, 28-37 (1990).
16. Moolgavkar, S. H., Luebeck, E. G., Krewski, D. and Zielinski, J. M. 'Radon, cigarette smoke, and lung cancer: a re-analysis of the Colorado plateau uranium miners' data', Epidemiology, 4, 204-217 (1993).
17. Moolgavkar, S. H. and Luebeck, E. G. 'Multistage carcinogenesis: population-based model for colon cancer', Journal of the National Cancer Institute, 84, 610-618 (1992).
18. Little, M. P. 'Are two mutations sufficient to cause cancer? Some generalizations of the two-mutation model of carcinogenesis of Moolgavkar, Venzon, and Knudson, and of the multi-stage model of Armitage and Doll', Biometrics, 51, 1278-1291 (1995).
19. Little, M. P. 'Generalisations of the two-mutation and classical multi-stage models of carcinogenesis fitted to the Japanese atomic bomb survivor data', Journal of Radiological Protection, 16, 17-24 (1996).
20. McKinney, P. A., Alexander, F. E., Cartwright, R. A., Scott, C. S. and Staines, A. 'Acute lymphoblastic leukaemia incidence in the UK by immunophenotype', Leukemia, 7, 1630-1634 (1993).
21. Office of Population Censuses and Surveys. Cancer Statistics Registrations, Series MB1 No. 1, 2, 4, 5, 7, 8, 10-16, 18-21, HMSO, London, 1979-1994.
22. Wheldon, T. E., Mairs, R. J., Barrett, A., Wheldon, E. G. and Gibson, B. E. 'Alternative models for early onset of childhood leukaemia', British Journal of Cancer, 66, (Suppl. XVIII), S13-S19 (1992).
23. NAG FORTRAN library introductory guide, Mark 15, Numerical Algorithms Group, Oxford, 1991.
24. McCullagh, P. and Nelder, J. A. Generalized Linear Models, 2nd edn, Chapman and Hall, London, 1989.
25. Morgan, B. J. T. Elements of Simulation Studies, Chapman and Hall, London, 1984.
26. Leukaemia Research Fund. Leukaemia and Lymphoma. An Atlas of Distribution within Areas of England and Wales 1984-1988, Leukaemia Research Fund, London, 1990.
27. Alexander, F., Ricketts, T. J., McKinney, P. A. and Cartwright, R. A. 'Cancer registration of leukaemias and lymphomas: results of a comparison with a specialist registry', Community Medicine, 11, 81-89 (1989).
28. Boice, J. D., Blettner, M., Kleinerman, R. A., et al. 'Radiation dose and leukemia risk in patients treated for cancer of the cervix', Journal of the National Cancer Institute, 79, 1295-1311 (1987).
29. Thomas, D. C., Blettner, M. and Day, N. E. 'Use of external rates in nested case-control studies with application to the International Radiation Study of Cervical Cancer patients', Biometrics, 48, 781-794 (1992).
30. Weiss, H. A., Darby, S. C. and Doll, R. 'Cancer mortality following X-ray treatment for ankylosing spondylitis', International Journal of Cancer, 59, 327-338 (1994).
31. Shimizu, Y., Kato, H. and Schull, W. J. 'Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 2. Cancer mortality based on the recently revised doses (DS86)', Radiation Research, 121, 120-141 (1990).
32. Preston, D. L., Kusumi, S., Tomonaga, M., et al. 'Cancer incidence in atomic bomb survivors. Part III: leukemia, lymphoma and multiple myeloma, 1950-1987', Radiation Research, 137, S68-S97 (1994).
33. Davis, D. L., Hoel, D., Fox, J. and Lopez, A. 'International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the USA', Lancet, 336, 474-481 (1990).
34. Doll, R. 'Progress against cancer: an epidemiologic assessment', American Journal of Epidemiology, 134, 675-688 (1991).
35. Cline, M. J. 'The molecular basis of leukemia', New England Journal of Medicine, 330, 328-336 (1994).
36. Seeker-Walker, L. M., Craig, J. M., Hawkins, J. M. and Hoffbrand, A. V. 'Philadelphia positive acute lymphoblastic leukemia in adults: age distribution, BCR breakpoint and prognostic significance', Leukemia, 5, 196-199 (1991).
37. Westbrook, C. A., Hooberman, A. L., Spino, C., et al. 'Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B study', Blood, 80, 2983-2990 (1992).
38. Diaz, M. O., Rubin, C. M., Harden, A., et al. 'Deletions of interferon genes in acute lymphoblastic leukemia', New England Journal of Medicine, 322, 77-82 (1990).
39. Thirman, M. J., Gill, H. J., Burnett, R. C., et al. 'Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations', New England Journal of Medicine, 329, 909-914 (1993).
40. Juliusson, G., Oscier, D. G., Fitchett, M., et al. 'Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities', New England Journal of Medicine, 323, 721-724 (1990).
41. Kornblau, S. M., Chen, N., del Giglio, A., O'Brien, S. and Deisseroth, A. B. 'Retinoblastoma protein expression is frequently altered in chronic lymphocytic leukemia', Cancer Research, 54, 242-246 (1994).
42. Sansoni, P., Cossarizza, A., Brianti, V., et al. 'Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians', Blood, 82, 2767-2773 (1993).
43. Green, M. H. L., O'Neill, J. P. and Cole, J. 'Suggestions concerning the relationship between mutant frequency and mutation rate at the hprt locus in human peripheral T-lymphocytes', Mutation Research, 334, 323-339 (1995).
44. Tawn, E. J. 'The frequency of chromosome aberrations in a control population', Mutation Research, 182, 303-308 (1987).
45. Tucker, J. D., Lee, D. A., Ramsey, M. J., Briner, J., Olsen, L. and Moore, D. H. 'On the frequency of chromosome exchanges in a control population measured by chromosome painting', Mutation Research, 313, 193-202 (1994).
46. Greaves, M. F. 'Speculations on the cause of childhood acute lymphoblastic leukemia', Leukemia, 2, 120-125 (1988).
47. Morris, J. A. 'The age incidence of childhood acute lymphoblastic leukaemia', Medical Hypotheses, 35, 4-10 (1991).